XML 41 R25.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
STOCKHOLDERS EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 29, 2024
Nov. 30, 2023
Oct. 28, 2023
Oct. 28, 2022
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Sep. 30, 2023
Incremental cost     $ 172,000            
Common stock shares issued 3,875,000 2,490,000     54,083,718   54,083,718   47,422,304
Public offering price $ 2 $ 2              
Proceeds from issuance of common stock $ 7,000,000 $ 4,500,000         $ 12,730,000 $ 0  
Net of issuance costs $ 700,000 $ 500,000              
Amortization Cost             $ 260,000    
Stock options         $ 234,332        
Consulting Agreements [Member]                  
Weighted average grant date fair value             $ 1.99 $ 2.47  
Options issued             5,000    
Exercise price             $ 11.61    
Consulting fees inclued prepaid expenses         351,000   $ 351,000   $ 205,000
Total expense         $ 152,000 $ 136,000 $ 370,000 $ 285,000  
Restricted Stock [Member] | Consultants [Member]                  
Weighted average grant date fair value         $ 2.22 $ 2.42 $ 2.24    
Common stock issued for service, shares         162,744 38,562 251,317 78,798  
Series RR [Member]                  
Incremental cost       $ 172,000